| Prev Close | 91.40 |
| Day Low/High | 88.23 / 91.33 |
| 52 Wk Low/High | 61.61 / 100.00 |
| Avg Volume | 10.60M |
Abbott Laboratories (ABT)
88.25
NYSE : Health Technology
| Exchange | NYSE |
| Shares Outstanding | 1.77B |
| Market Cap | 161.67B |
| EPS | 2.10 |
| P/E Ratio | 44.15 |
| Div & Yield | 1.44 (1.47%) |
Even the Fed Can't Make Stocks Budge
Movement has become difficult after weeks of advances, which suggests a downturn may be near.
Jim Cramer Says You Want to Own This Health Care Stock
Jim Cramer believes Abbott Labs' CEO Miles White is doing a terrific job of making the company better.
Stericycle Is a Good Shorting Candidate
This stock is well into overbought territory.
Small-Cap 'Mutiny' Spells Trouble
The Russell 2000's failure to follow the S&P and Dow's lead is only one reason for concern.
Alere's Stock Spikes Following News of Its Impending Buy by Abbott
Shares of Alere soared on Monday on word that Abbott Labs would acquire the company in a deal valued at $7.9 billion.
Health Care Stocks Are Getting 'Uber-ed' by Ashton Kutcher
Two significant, but subtle forces may threaten the group in the next 12 months.
Cramer: Dow Chemical-DuPont Merger Will Instantly Create Value
The merged company can become multiple companies.
Don't Abandon the Biotech Ship
There's too much good out there.
The Book of Boockvar
Peter Boockvar looks at China, the European Central Bank and the Bank of Japan this morning: "According to the Chinese, their economy grew 6.9% y/o/y in the third quarter vs. 7% in the second quarter and vs. a 6.8% estimate. While we'll take that wi...
Drug Stocks' Earnings Power Won't Go Away
Before you sell them, ask yourself at what multiple you sell.
AbbVie Has More Downside to Go
The stock has shown awful relative strength.
Jim Cramer Says Retail Investors Should Wait to Buy Stocks
Stocks climbed early Thursday, but Jim Cramer, portfolio manager of Action Alerts PLUS, remains cautious still.
Market Wrap: IBM and United Tech a Real Drag
IBM and UTX accounted for two-thirds of the Dow's 1% drop, and Apple and Microsoft fall after-hours..
The Stock Market Is Treacherous, Perilous, and Ultra-Rewarding
This market is almost entirely special situation.
3 Dividend Hikes This Week You Should Know About
Duke Energy's recent increase puts its payout at the high end of the industry range.
Obamacare Ruling Means the Debate Is Over
As health-care stocks rally, it's time for politicians to move on.
AbbVie Is Knocking on the Door Again
The ABBV chart looks constructive, with solid volume and bullish indicators.
Charter Communications Hopes to Succeed Where Comcast Didn't
Durable Goods orders fell a half percent in April matching estimates.
The Second-Strongest Stock Market Sector Doesn't Jibe With the Strongest
You could throw darts at financials and health care and win.
Day Ahead: Earnings, Housing Data Dominate
And have we mentioned Greece?
Earnings Growth Boosts AbbVie
Drug franchises are still going strong.
Cramer: Spinoffs Are in Vogue
The logic of owning the pure play is attractive.
Dividend Hikes Provide a Holiday Treat
It's worth looking at the dividend payers this time of year.
